Rubicon Research Limited (NSE:RUBICON)
772.25
-8.45 (-1.08%)
At close: Feb 12, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 129.25 billion as of February 13, 2026.
Market Cap
129.25B
Enterprise Value
133.42B
Revenue
15.98B
Ranking
n/a
PE Ratio
60.19
Stock Price
772.25
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 129.25B, an increase of 24.89%. That is a compound annual growth rate of 96.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 129.25B | 15.25% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 425.38B |
| J. B. Chemicals & Pharmaceuticals | 302.43B |
| AstraZeneca Pharma India | 216.90B |
| Jubilant Pharmova | 148.25B |
| Granules India | 138.04B |
| Caplin Point Laboratories | 133.80B |
| CORONA Remedies | 100.03B |
| Sanofi India | 92.34B |